S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Aflac (AFL) Stock Price, News & Analysis

$80.41
+0.76 (+0.95%)
(As of 02/23/2024 ET)
Today's Range
$79.56
$80.55
50-Day Range
$76.20
$85.74
52-Week Range
$60.20
$86.20
Volume
1.87 million shs
Average Volume
2.26 million shs
Market Capitalization
$46.99 billion
P/E Ratio
10.38
Dividend Yield
2.49%
Price Target
$80.36

Aflac MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
0.1% Downside
$80.36 Price Target
Short Interest
Bearish
1.94% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.15
Upright™ Environmental Score
News Sentiment
0.78mentions of Aflac in the last 14 days
Based on 22 Articles This Week
Insider Trading
Selling Shares
$2.93 M Sold Last Quarter
Proj. Earnings Growth
6.38%
From $6.43 to $6.84 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.38 out of 5 stars

Finance Sector

215th out of 858 stocks

Accident & Health Insurance Industry

2nd out of 4 stocks


AFL stock logo

About Aflac Stock (NYSE:AFL)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.

AFL Stock Price History

AFL Stock News Headlines

Pegasystems flies on AI decision and workflow automation platform (AFL)
Pegasystems stock gapped up after reporting strong demand for its AI-powered CRM and BPM solutions; the company raised its full-year guidance
The Retirement of Your Dreams Awaits You…
Imagine it's 2025 and you have the financial freedom to pursue any of your biggest goals. All of this because YOU decided to take action in 2024. The Bitcoin Halving in 2024 could change your life forever...And the strategies outlined in the Crypto Retirement Blueprint will give you what you need to be able to crush the upcoming halving cycle bull run, and potentially retire quickly in wealth.
Decoding Aflac Inc (AFL): A Strategic SWOT Insight
Bank of America Securities Financial Services Conference
The World's First "$20 Trillion Drug
?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>
Warren Buffett's Secret Stock Pick? Our Top 3 Guesses
AFL Feb 2024 74.000 call
Aflac: A Dividend Aristocrat To Watch
Unveiling 5 Analyst Insights On Aflac
Q4 2023 Aflac Inc Earnings and Outlook Call
See More Headlines
Receive AFL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aflac and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/01/2024
Ex-Dividend for 3/1 Dividend
2/20/2024
Today
2/23/2024
Dividend Payable
3/01/2024
Next Earnings (Estimated)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Accident & health insurance
Sub-Industry
Life & Health Insurance
CUSIP
00105510
CIK
4977
Employees
12,882
Year Founded
1955

Price Target and Rating

Average Stock Price Target
$80.36
High Stock Price Target
$88.00
Low Stock Price Target
$74.00
Potential Upside/Downside
0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
11 Analysts

Profitability

Net Income
$4.66 billion
Pretax Margin
28.14%

Debt

Sales & Book Value

Annual Sales
$18.70 billion
Cash Flow
$7.42 per share
Book Value
$37.62 per share

Miscellaneous

Free Float
579,121,000
Market Cap
$46.97 billion
Optionable
Optionable
Beta
0.93

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Should I Buy Aflac Stock? AFL Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Aflac was last updated on Thursday, February 22, 2024 at 8:27 PM.

Pros

Here are some ways that investors could benefit from investing in Aflac Incorporated:

  • Aflac has a strong market presence in both Japan and the United States, offering a diverse range of supplemental health and life insurance products.
  • The company has a solid track record of financial performance, with a return on equity of 17.59% and a net margin of 24.92%.
  • Aflac's stock price has shown resilience, with a 52-week range between $60.20 and $86.20, indicating stability and potential for growth.
  • Despite missing earnings estimates in the last quarter, analysts anticipate Aflac to post 6.43 earnings per share for the current fiscal year, showing positive growth potential.
  • Aflac's market cap of $45.38 billion and a PE ratio of 10.17 suggest a strong financial position and reasonable valuation.

Cons

Investors should be bearish about investing in Aflac Incorporated for these reasons:

  • Aflac's recent earnings report showed a miss on analysts' consensus estimates, indicating potential challenges in meeting financial expectations.
  • The company's revenue of $3.78 billion for the last quarter fell short of analyst estimates of $4.44 billion, raising concerns about revenue growth.
  • Aflac's debt-to-equity ratio of 0.33 may raise concerns about the company's leverage and financial risk.
  • The stock's 50-day moving average of $82.24 is below the 200-day moving average of $79.10, suggesting a short-term bearish trend.
  • Insiders have been selling shares of Aflac, as seen in recent filings, which could signal lack of confidence in the company's future performance.














AFL Stock Analysis - Frequently Asked Questions

Should I buy or sell Aflac stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aflac in the last year. There are currently 2 sell ratings, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AFL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFL, but not buy additional shares or sell existing shares.
View AFL analyst ratings
or view top-rated stocks.

What is Aflac's stock price target for 2024?

11 equities research analysts have issued twelve-month target prices for Aflac's stock. Their AFL share price targets range from $74.00 to $88.00. On average, they anticipate the company's stock price to reach $80.36 in the next twelve months. This suggests that the stock has a possible downside of 0.1%.
View analysts price targets for AFL
or view top-rated stocks among Wall Street analysts.

How have AFL shares performed in 2024?

Aflac's stock was trading at $82.50 at the beginning of 2024. Since then, AFL shares have decreased by 2.5% and is now trading at $80.41.
View the best growth stocks for 2024 here
.

When is Aflac's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our AFL earnings forecast
.

How were Aflac's earnings last quarter?

Aflac Incorporated (NYSE:AFL) announced its quarterly earnings data on Thursday, February, 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts' consensus estimates of $1.47 by $0.22. The financial services provider had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a net margin of 24.92% and a trailing twelve-month return on equity of 17.59%. During the same quarter in the previous year, the firm earned $1.29 EPS.
Read the conference call transcript
.

How often does Aflac pay dividends? What is the dividend yield for Aflac?

Aflac declared a quarterly dividend on Wednesday, November 1st. Shareholders of record on Wednesday, February 21st will be given a dividend of $0.42 per share on Friday, March 1st. This represents a $1.68 annualized dividend and a dividend yield of 2.09%. The ex-dividend date of this dividend is Tuesday, February 20th.
Read our dividend analysis for AFL
.

Is Aflac a good dividend stock?

Aflac (NYSE:AFL) pays an annual dividend of $2.00 per share and currently has a dividend yield of 2.52%. The dividend payout ratio is 25.81%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AFL will have a dividend payout ratio of 29.24% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for AFL.

When did Aflac's stock split?

Shares of Aflac split on Monday, March 19th 2018. The 2-1 split was announced on Tuesday, February 13th 2018. The newly issued shares were payable to shareholders after the market closes on Friday, March 16th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Aflac's stock buyback program work?

Aflac announced that its board has authorized a stock buyback program on Tuesday, November 8th 2022, which allows the company to repurchase 100,000,000 shares, according to EventVestor. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.

What is Dan Amos' approval rating as Aflac's CEO?

435 employees have rated Aflac Chief Executive Officer Dan Amos on Glassdoor.com. Dan Amos has an approval rating of 93% among the company's employees. This puts Dan Amos in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 68.0% of employees surveyed would recommend working at Aflac to a friend.

What other stocks do shareholders of Aflac own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aflac investors own include AT&T (T), Johnson & Johnson (JNJ), AbbVie (ABBV), Exxon Mobil (XOM), Pfizer (PFE), McDonald's (MCD), Medtronic (MDT), Cisco Systems (CSCO), Intel (INTC) and Verizon Communications (VZ).

Who are Aflac's major shareholders?

Aflac's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.97%), Wells Fargo & Company MN (2.77%), Northern Trust Corp (1.18%), Legal & General Group Plc (0.96%), First Trust Advisors LP (0.93%) and LSV Asset Management (0.79%). Insiders that own company stock include Albert Riggieri, Arthur Reginald Collins, Audrey B Tillman, Barbara K Rimer, Charles D Lake II, Eric M Kirsch, Frederick John Crawford, Georgette D Kiser, James Todd Daniels, Joseph L Moskowitz, June P Howard, Karole Lloyd, Masatoshi Koide, Steven Kent Beaver, Teresa L White, Thomas J Kenny, Toshihiko Fukuzawa, Virgil Raynard Miller and William P Bowers.
View institutional ownership trends
.

How do I buy shares of Aflac?

Shares of AFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Aflac have any subsidiaries?
The following companies are subsidiares of Aflac: AGV Management Services Japan KK, Aflac Asset Management Japan Ltd., Aflac Asset Management LLC, Aflac Benefits Advisors, Aflac Corporate Ventures LLC, Aflac Global Ventures LLC, Aflac Heartful Services Co., Aflac Holdings LLC, Aflac InfoSec Services LLC, Aflac Information Technology, Aflac Innovation Partners G.K., Aflac Insurance Services Co., Aflac Insurance Services Co. Ltd., Aflac International, Aflac Life Insurance Japan Ltd., Aflac Northern Ireland Ltd., Aflac Payment Services Co., Aflac Ventures India Fund LLC, Aflac Ventures LLC, Aflac Ventures Labs LLC, Aflac Ventures Seed Fund LLC, American Family Life Assurance Company of Columbus, American Family Life Assurance Company of New York, Apollo AF Loan Trust, Argus Dental & Vision Inc, Argus Holdings LLC, Communicorp, Continental American Group, Continental American Insurance Company, Empowered.Insure LLC, Empoweredbenefits, Empoweredbenefits LLC, Global Alternatives Private Equity Sub-Trust A, Global Investment Fund I, Hatch Healthcare KK, Hatch Insight KK, Lapetus Solutions Inc., Medical Note Inc., NIO Innovative Technologies Ltd., Octagon Delaware Trust, Picwell Inc., SUDACHI Small-amount Short-term Preparation Company Ltd., Sensely Corporation, Simple Technology LLC, Tier One Insurance Company, Tsusan Co. Ltd., Varagon Capital Management MGP LLC, Varagon Capital Partners L.P., Wellthie Inc., and Zurich North America’s U.S..
Read More
This page (NYSE:AFL) was last updated on 2/23/2024 by MarketBeat.com Staff